Literature DB >> 23715595

Critical appraisal of clinical practice guidelines for adaptation in the evidence-based guideline "prevention of skin cancer".

Sonia Petrarca1, Markus Follmann, Eckhard W Breitbart, Sandra Nolte.   

Abstract

IMPORTANCE: During guideline development, it is essential to systematically review existing guidelines that may be suitable for adaptation; however, such review is laborious and may not always uncover useful guidelines.
OBJECTIVE: To identify existing clinical practice guidelines and assess their methodologic quality and suitability for adaptation in the German evidence-based guideline "Prevention of Skin Cancer." EVIDENCE ACQUISITION: A systematic literature search was performed across a range of databases and homepages of guideline development institutions. The AGREE Instrument (Appraisal of Guidelines Research and Evaluation) was used to assess the methodologic quality of selected guidelines.
RESULTS: A total of 480 citations were identified and screened. Of these, 12 guidelines were deemed suitable for potential adaptation. After comprehensive quality assessment, only 2 melanoma guidelines, one from Australia/New Zealand and the other from Scotland, were identified as being of high methodologic quality according to predefined selection criteria. Subsequent synopsis, however, revealed that neither of these guidelines was sufficiently comprehensive for full adaptation. CONCLUSIONS AND RELEVANCE: It is surprising that most existing skin cancer guidelines that contain aspects on prevention are not appropriate for adaptation, with most lacking methodologic quality, particularly rigor applied during the development process. Of the 2 guidelines that met the predefined quality criteria, only a few aspects--limited to malignant melanoma--were adaptable. We conclude that, despite the labor-intensive search for existing guidelines, a de novo development, including systematic literature review, is indispensible for the development of the German evidence-based guideline Prevention of Skin Cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23715595     DOI: 10.1001/jamadermatol.2013.3306

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  1 in total

1.  Evaluating the strength of clinical recommendations in the medical literature: GRADE, SORT, and AGREE.

Authors:  Mayra Buainain de Castro Maymone; Stephanie D Gan; Michael Bigby
Journal:  J Invest Dermatol       Date:  2014-10       Impact factor: 8.551

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.